Patients with an event during follow up
| Patient/ sex | Age (years) |
RD (mm) |
MLD (mm) |
DS (%) | FFR LM | Initial treatment | Event, treatment of event (days to event) |
| Medical group (FFR ⩾ 0.75) | |||||||
| 1/M | 61 | 4.30 | 2.61 | 40 | 0.85 | Medical treatment | Exercise test positive, CAG, disease progression proximal LAD, PTCA (82) |
| 2/F | 70 | 4.01 | 2.10 | 48 | 0.96 | PTCA LAD | CAG, restenosis LAD, re-do PTCA (118) |
| 3/M | 42 | 4.51 | 1.93 | 57 | 0.95 | Medical treatment | Exercise test positive, CAG, disease progression LM, CABG (482) |
| 4/F | 49 | 2.98 | 2.18 | 27 | 0.95 | Medical treatment | Exercise test positive, CAG, disease progression LM, CABG (845) |
| 5/M | 68 | 5.57 | 2.45 | 56 | 0.96 | PTCA LCX | Exercise test positive, CAG, new stenosis LAD and RCA, CABG (1293) |
| Surgical group (FFR < 0.75) | |||||||
| 6/F | 70 | 4.48 | 2.76 | 38 | 0.50 | LITA LAD | Postoperative ischaemia, redo thoracotomy, SVG LAD (0) |
| 7/M | 61 | 2.41 | 1.80 | 25 | 0.62 | Left main reconstruction, SVG RCA | Postoperative ischaemia, anterior myocardial infarction (0) |
| 8/M | 75 | 3.89 | 2.68 | 31 | 0.72 | LITA LAD, SVG RCA, SVG LCx, AVR | Postoperative mitral regurgitation, valve replacement (0) |
| 9/M | 66 | 3.02 | 1.54 | 49 | 0.73 | LITA LAD | Postoperative ischaemia, redo thoracotomy, SVG LAD (0) |
| 10/M | 81 | 3.92 | 1.65 | 58 | 0.63 | LITA LAD, SVG jump D1-LCx-RCA | Postoperative ARDS and pneumonia, death (29) |
ARDS, acute respiratory distress syndrome; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; CAG, coronary angiography; DS, diameter stenosis; D1, first diagonal branch; F, female; FFR, fractional flow reserve; LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; LITA, left interthoracic artery; M, male; MLD, minimum lumen diameter; PTCA, percutaneous transluminal coronary angioplasty; RCA, right coronary artery; RD, reference diameter; SVG, saphenous vein graft.